COMPANY BUSINESS (INCLUDING MAIN COUNTRY OF OPERATION) OR, IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITS INVESTING POLICY). IF THE ADMISSION IS SOUGHT AS A RESULT OF A REVERSE TAKE-OVER UNDER RULE 14, THIS SHOULD BE STATED: Trellus Health is commercialising the provision of digital chronic condition management solutions for employers and health plans that utilise the scientifically validated GRITT™ resilience-based methodology and a proprietary HIPAA-compliant technology platform called TrellusElevate™ to coordinate and deliver care remotely via telemedicine. The Company is initially focused on Inflammatory Bowel Diseases (IBD), which include the chronic incurable conditions of Crohn s Disease and ulcerative colitis, but considers its approach to have potential utility and demand across many chronic conditions.
Trellus Health Announces Experienced Leaders to Drive Next Phase of Growth
Industry veterans from Teladoc Health, Talkspace, Harwood Capital and Polar Capital join executive team and board of directors
News provided by
Share this article
Share this article
WHITE PLAINS, N.Y., May 3, 2021 /PRNewswire/ Trellus Health, a leading resilience-driven connected health solution for chronic conditions, announced several important additions to its executive team and board of directors.
The company named Alex Kozersky as Chief Sales Officer, Robert Birdsong as Chief Marketing Officer and Carole Romasco as Vice President of Product Management. Jaime King was promoted to Vice President of Compliance, Operations, and Human Resources.
EXECUTIVE CHANGES: Ebiquity appoints ITV executive Izlan to board
Mon, 26th Apr 2021 16:02
(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and not separately reported by Alliance News:
Ebiquity PLC - marketing and media consultancy - Appoints Lara Izlan as non-executive director with effect on June 1. Is currently director of Data Strategy at FTSE-250 listed broadcaster ITV PLC.
Arix Bioscience PLC - firm which invests in biotech companies - Acacia Research Corp, a 19% shareholder in Arix will requisition resolutions for Arix s annual general meeting, nominating the appointment of Peregrine Moncreiffe, Issac Kohlberg and Maureen O Connell to the company s board. Moncreiffe is chair of North Atlantic Smaller Companies Investment Trust PLC and Kohlberg is chief technology development officer for Harvard University.
A
Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body; 4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;